PSY7 - Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients
- Resource Type
- Abstract
- Source
- In
Value in Health October-November 2017 20(9):A545-A545 - Subject
- Language
- ISSN
- 1098-3015